16/01/2004

Kilkeel company sees innovative seat idea 'take off'

A revolutionary approach to increase passenger comfort and safety on passenger flights has been developed by Kilkeel-based J Thompson Solutions (JTS).

The idea for an innovative seat design and cabin configuration has been developed by the company in response to increasing concern amongst the flying public about the threat of deep vein thrombosis (DVT).

The new seat incorporates specialist foam adapted from the medical sector, which promotes circulation, and a pedal system on the base of each seat to allow passengers to exercise whilst sitting. The overall seat structure allows greater freedom and space in economy class owing to a tilting movement of the seat shell within a fixed space which eliminates the need to recline the seat into the passenger directly behind.

The company has also developed a unique cabin configuration that maximises the leg and elbowroom available to passengers without compromising the number of seats on an aircraft, which means both traveller and airline benefit.

These innovations have been brought to life with support from Invest NI towards prototyping and marketing and have captured the interest of the world's major airlines since their launch at the Aircraft Interiors show.

James Thompson, managing director of JTS, has been involved in the design and development of some of the most revolutionary products in the airline industry, including Virgin Atlantic's upper-class sleeper seat, before setting up his own design company a few years ago.

He said: “We’ve had a very positive reception from the sector to the new concept, and are now in negotiations with major players in the industry. Invest NI’s support for the development of the prototype and its launch was absolutely key to our being able to bring our ideas to the marketplace.”

These recent developments will mean strengthening the management team through key appointments and will create a number technical design positions to deal with demand from the aircraft sector.

Anne Beggs, Invest NI client executive, said: “JTS has developed a highly innovative concept that delivers a solution to the aerospace industry and has the potential to make this small design company a global player.

“Knowledge based companies such as this are vital to the success of the Northern Ireland economy. Invest NI has worked closely with JTS in developing and marketing the concept and will continue to work with the business to commercialise its innovations in the international marketplace."

(SP)

Related Northern Ireland News Stories
Click here for the latest headlines.

19 February 2024
SDLP Calls For End To The Uncertainty Over Public Finances
The SDLP has called on Ministers to put an end to the uncertainty over public finances at the first substantive meeting of the Executive.
16 February 2024
£688m Announced For Public Sector Pay Awards
£688 million has been announced to prioritise public sector pay awards, Finance Minister, Dr Caoimhe Archibald MLA has announced. The allocation was part of the £1.045bn available from the Executive Restoration package for general pressures and pay in 2023-24. Some £22 million of resource funding was also available from the Executive’s own funds.
24 January 2024
SDLP Proposes Amendment To Executive Formation Bill
The SDLP has said that it will seek to amend proposed legislation extending the deadline for the formation of an Executive after the previous deadline passed last week.
18 January 2024
Thousands Of Public Sector Workers Begin Strike Action
Northern Ireland's largest strike in around 50 years has gotten underway today, 18 January. Around 170,000 public sector workers are taking part in the industrial action. Members from over 15 unions including health, education and transport workers are taking part in the day of mass industrial action.
29 February 2024
New Strategy For Future Development Of General Practice Pharmacy Sector
A new strategy for the future development of the General Practice Pharmacy sector has been published by the Department of Health following positive evaluation of its benefits.